Cutaneous Breast Cancer Metastases Successfully Treated Using an Oxygen Flow Assisted Topical Administration of Methotrexate (OFAMTX).
Gaëlle JouretElodie GonnePascale QuatresoozMarie-Annick ReginsterPatrick CollinsEve LebasGuy JerusalemArjen F NikkelsPublished in: Dermatology and therapy (2020)
OFAMTX5% represents an alternative skin-directed, painless, patient-friendly and efficacious adjuvant treatment for superficial metastatic lesions of breast cancer. Larger series are required to evaluate the potential of OFAMTX5% for the treatment of superficial metastatic lesions of breast cancer.